Chemical Component Summary

Name (9cis)-retinoic acid
Identifiers (2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
Formula C20 H28 O2
Molecular Weight 300.435  g/mol
Isomeric SMILES C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O
InChI InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8-,16-14+

Chemical Details

Formal Charge 0
Atom Count 50
Chiral Atom Count 0
Chiral Atoms n/a
Bond Count 50
Aromatic Bond Count 0
Leaving Atoms n/a

Drug Info: DrugBank

DrugBank ID DB00523   (Stereoisomeric match)
Name Alitretinoin
  • approved
  • investigational
Description An important regulator of gene expression during growth and development, and in neoplasms. Tretinoin, also known as retinoic acid and derived from maternal vitamin A, is essential for normal growth; and embryonic development. An excess of tretinoin can be teratogenic. It is used in the treatment of psoriasis; acne vulgaris; and several other skin diseases. It has also been approved for use in promyelocytic leukemia (leukemia, promyelocytic, acute). [PubChem]
  • (2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
  • (7e,9Z,11e,13e)-Retinoic acid
  • 9-cis-Retinoic acid
  • 9-cis-Tretinoin
  • 9(Z)-Retinoic acid
Brand Names
  • Panretin
  • Toctino
Affected Organism Humans and other mammals
Indication For topical treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma.
Pharmacology Alitretinoin (9-<i>cis</i>-retinoic acid) is a naturally-occurring endogenous retinoid indicated for topical treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma. Alitretinoin inhibits the growth of Kaposi's sarcoma (KS) cells <i>in vitro</i>.
Mechanism of action Alitretinoin binds to and activates all known intracellular retinoid receptor subtypes (RARa, RARb, RARg, RXRa, RXRb and RXRg). Once activated these receptors function as transcription factors that regulate the expression of genes that control the process of cellular differentiation and proliferation in both normal and neoplastic cells.
Route of administration
  • oral
  • topical
Categories Antineoplastic Agents
  • D11AH04
  • L01XX22
  • 84:16.00
  • 92:00.00
CAS number 5300-03-8
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682